13F HOLDINGS REPORT
Patient Square Capital LP
Quarter ended Q3 2025 · Filed November 10, 2025 · Accession 0001819257-25-000002
Total Value
$373.9M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | ROIV | 12,480,000 | $188.8M | 50.51% |
| 2 | INSMED INC | INSM | 326,400 | $47.0M | 12.57% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,011,839 | $14.4M | 3.85% |
| 4 | ABIVAX SA | AAVXF | 151,833 | $12.9M | 3.45% |
| 5 | CIDARA THERAPEUTICS INC | 171757206 | 121,000 | $11.6M | 3.10% |
| 6 | ARGENX SE | ARGX | 15,500 | $11.4M | 3.06% |
| 7 | LIQUIDIA CORPORATION | LQDA | 400,000 | $9.1M | 2.43% |
| 8 | PHARVARIS N V | PHVS | 345,381 | $8.6M | 2.30% |
| 9 | OCULAR THERAPEUTIX INC | OCUL | 715,000 | $8.4M | 2.24% |
| 10 | MIRUM PHARMACEUTICALS INC | MIRM | 104,262 | $7.6M | 2.04% |
| 11 | AGIOS PHARMACEUTICALS INC | AGIO | 133,827 | $5.4M | 1.44% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 92,592 | $5.2M | 1.40% |
| 13 | ENLIVEN THERAPEUTICS INC | ELVN | 250,838 | $5.1M | 1.37% |
| 14 | CELCUITY INC | CELC | 100,000 | $4.9M | 1.32% |
| 15 | DIANTHUS THERAPEUTICS INC | DNTH | 125,000 | $4.9M | 1.32% |
| 16 | DISC MEDICINE INC | IRON | 74,000 | $4.9M | 1.31% |
| 17 | UNIQURE NV | QURE | 75,000 | $4.4M | 1.17% |
| 18 | AMYLYX PHARMACEUTICALS INC | AMLX | 316,312 | $4.3M | 1.15% |
| 19 | NURIX THERAPEUTICS INC | NRIX | 437,237 | $4.0M | 1.08% |
| 20 | ALLOGENE THERAPEUTICS INC | ALLO | 2,981,396 | $3.7M | 0.99% |
| 21 | ASSEMBLY BIOSCIENCES INC | ASMB | 135,182 | $3.5M | 0.93% |
| 22 | AVALO THERAPEUTICS INC | AVTX | 100,000 | $1.3M | 0.34% |
| 23 | PERSPECTIVE THERAPEUTICS INC | CATX | 349,323 | $1.2M | 0.32% |
| 24 | GERON CORP | GERN | 845,000 | $1.2M | 0.31% |